Quantcast

Latest thyroid cancer Stories

2014-03-29 23:01:26

The Firm is investigating Byetta lawsuits on behalf of individuals who allegedly developed pancreatic cancer, pancreatitis or thyroid cancer due to their use of Byetta. New York, New York (PRWEB) March 29, 2014 As Byetta lawsuits (http://www.byettalawsuit.com) continue to move forward in federal court, Bernstein Liebhard LLP notes that a newly published study is raising questions about the costs and benefits associated with newer medications used in the treatment of Type 2 diabetes....

2014-03-01 23:01:16

The Firm is actively investigating Byetta lawsuit claims on behalf of diabetics who may have been diagnosed with pancreatitis, pancreatic cancer or thyroid cancer after taking the medication. New York, New York (PRWEB) March 01, 2014 The federal litigation of Byetta lawsuits (http://www.byettalawsuit.com/) and other claims involving similar Type 2 diabetes drugs has grown to include more than 300 cases, Bernstein Liebhard LLP reports. According to a Case List updated February 19th by the...

2014-02-25 13:41:11

A new analysis has found that adolescents and young adults who develop thyroid cancer as a secondary cancer have a significantly greater risk of dying than those with primary thyroid cancer. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the findings stress the importance of screening young cancer survivors to detect early signs of a potentially life-threatening thyroid malignancy. Thyroid cancer is one of the five most common malignancies in...

2014-02-22 23:01:04

The Firm is evaluating Byetta lawsuits on behalf of patients who allegedly developed pancreatic cancer, pancreatitis, or thyroid cancer due to their use of the Type 2 diabetes medication. New York, New York (PRWEB) February 22, 2014 A Byetta lawsuit (http://www.byettalawsuit.com) Plaintiff has withdrawn her motion seeking the consolidation of all federal claims involving allegations that the Type 2 diabetes drug caused patients to develop thyroid cancer, Bernstein Liebhard LLP reports....

2014-02-17 23:03:29

The Firm is investigating Byetta lawsuits on behalf of individuals who developed pancreatic cancer, thyroid cancer or pancreatitis, allegedly due to their use of the Type 2 diabetes medication. New York, New York (PRWEB) February 17, 2014 The federal court overseeing dozens of Byetta lawsuits (http://www.byettalawsuit.com) and other product liability claims involving Type 2 diabetes drugs known as incretin mimetics is now considering proposals for the case management of the...

2014-02-14 23:23:27

Molecular diagnostic testing, which analyzes thyroid nodule FNA biopsy specimens, is rapidly emerging as a useful tool for evaluation of cytologically indeterminate thyroid nodules that otherwise would require diagnostic surgery. Portland, OR (PRWEB) February 14, 2014 Molecular diagnostic testing, which analyzes thyroid nodule FNA biopsy specimens, is rapidly emerging as a useful tool for evaluation of cytologically indeterminate thyroid nodules that otherwise would require diagnostic...

2014-02-13 23:01:43

The Firm is evaluating Byetta lawsuits and other legal claims on behalf of individuals who allegedly developed pancreatic cancer, pancreatitis, and thyroid cancer due their use of incretin mimetic medications used to treat Type 2 diabetes. New York, New York (PRWEB) February 13, 2014 As Byetta lawsuits (http://www.byettalawsuit.com) and other legal claims involving incretin mimetic drugs continue to move forward in U.S. courts, Bernstein Liebhard LLP notes that U.S. health regulators...

2014-02-03 00:21:05

WOODCLIFF LAKE, N.J., Feb. 2, 2014 /PRNewswire/ -- Eisai Inc. announced today that the Phase 3 SELECT trial (Study 303) of investigational agent lenvatinib met its primary endpoint. Compared to placebo, lenvatinib showed a highly statistically significant improvement in progression free survival (PFS) in patients with radioiodine-refractory differentiated thyroid cancer (RR-DTC). The preliminary safety analyses showed that the five most common adverse reactions were hypertension,...

Thyroid Cancer Cells Less Aggressive In Space
2014-01-30 14:34:41

Lee Rannals for redOrbit.com - Your Universe Online In the future, individuals suffering from thyroid cancer may be taking a trip outside of Earth’s atmosphere as a form of treatment. Researchers writing in the FASEB Journal say that thyroid cancer cells are less aggressive in space than on Earth. The team said that aggressive earth-bound cells experience a redifferentiation when journeying to microgravity, placing them in a less aggressive state. Scientists believe that this finding...

2014-01-29 23:04:46

The Firm is currently evaluating Byetta lawsuits on behalf of individuals who allegedly developed pancreatic cancer, thyroid cancer, or pancreatitis due to their use of the Type 2 diabetes drugs. New York, New York (PRWEB) January 29, 2014 As Byetta lawsuits (http://www.byettalawsuit.com ) continue to mounts in courts around the country, Bernstein Liebhard LLP notes that plaintiffs in federally-filed lawsuits involving allegations that use of the drug caused thyroid cancer have filed a...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.